SANGAMO THERAPEUTICS, INC. (SGMOQ) Revenue 2016–2025
SANGAMO THERAPEUTICS, INC. (SGMOQ) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$39.6MFY2025 · since FY2016: $19.4M → $39.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $39.6M | -31.6% |
| FY2024 | $57.8M | -67.2% |
| FY2023 | $176.2M | +58.3% |
| FY2022 | $111.3M | +0.5% |
| FY2021 | $110.7M | -6.3% |
| FY2020 | $118.2M | +15.4% |
| FY2019 | $102.4M | +21.3% |
| FY2018 | $84.5M | +131.0% |
| FY2017 | $36.6M | +88.6% |
| FY2016 | $19.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice